Drug Target Review

2 weeks ago | drugtargetreview.com | Carrie Haslam

Posted: 9 June 2025 | Drug Target Review | A new study suggests statins, cheap and widely used cholesterol drugs, could be repurposed to reduce the risk of death from sepsis. Researchers reported a 39 percent drop in 28-day mortality, highlighting their potential role in critical care. A major new study has found that statins could significantly reduce the risk of death in patients with severe sepsis.

3 weeks ago | drugtargetreview.com | Carrie Haslam

Posted: 5 June 2025 | Drug Target Review | A rare genetic glitch causes dopamine to leak in the brain – now researchers may have found a way to stop it, without the risks of current treatments. A new study led by scientists at Florida Atlantic University (FAU) offers a promising step forward in the treatment of dopamine-related neuropsychiatric disorders. Unlike current therapies, it avoids the high risk of side effects and addiction.

3 weeks ago | drugtargetreview.com | Carrie Haslam

Posted: 2 June 2025 | Drug Target Review | Researchers at the University of Illinois have achieved the first successful metabolic labelling of platelets, a key step toward using them in targeted drug delivery. The technique could enable short-lived, precision therapies for cancer, immune conditions, and clotting disorders.

4 weeks ago | drugtargetreview.com | Carrie Haslam

articlePosted: 30 May 2025 | Carrie Haslam | Forget the buzzwords – SLAS 2025 showed what’s genuinely driving progress in drug discovery: usable AI, collaborative platforms and tools that solve real problems. Drug Target Review had the pleasure of attending SLAS Europe 2025 in Hamburg and what we saw was no mere showcase of cutting-edge tools, but a clear snapshot of where drug discovery is heading.

2 months ago | drugtargetreview.com

Explore the latest research on polycystic kidney disease and its implications in understanding the role of the worm.